A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

NCT04050670 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company